BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27273957)

  • 1. E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis.
    Tsiambas E; Ragos V; Georgakopoulos G; Rigopoulos DN; Fotiades PP; Chatziioannidis A; Stamatelopoulos A; Vilaras G; Karameris A
    J BUON; 2016; 21(2):450-5. PubMed ID: 27273957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta- and gamma-catenin expression in thyroid carcinomas.
    Cerrato A; Fulciniti F; Avallone A; Benincasa G; Palombini L; Grieco M
    J Pathol; 1998 Jul; 185(3):267-72. PubMed ID: 9771480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune expression of E-cadherin and α, β and γ-Catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas.
    Reis ST; Leite KR; Mosconi Neto A; Pontes Júnior J; Viana NI; Antunes AA; Dall'Oglio MF; Srougi M
    Int Braz J Urol; 2012; 38(4):466-73. PubMed ID: 22951176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
    Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
    J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of E-cadherin, alpha- and beta-catenins in papillary thyroid carcinoma.
    Kapran Y; Ozbey N; Molvalilar S; Sencer E; Dizdaroğlu F; Ozarmağan S
    J Endocrinol Invest; 2002; 25(7):578-85. PubMed ID: 12150330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
    Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
    Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin gene alterations are rare events in thyroid tumors.
    Soares P; Berx G; van Roy F; Sobrinho-Simões M
    Int J Cancer; 1997 Jan; 70(1):32-8. PubMed ID: 8985087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue.
    Huang SH; Wu JC; Chang KJ; Liaw KY; Wang SM
    Thyroid; 1999 Nov; 9(11):1095-103. PubMed ID: 10595458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.
    Zhai B; Yan HX; Liu SQ; Chen L; Wu MC; Wang HY
    World J Gastroenterol; 2008 Oct; 14(37):5665-73. PubMed ID: 18837082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
    Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
    Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of E-cadherin in thyroid neoplastic tissues and its correlation with malignant and metastatic potential].
    Naitoh A; Kobayashi S; Iwase H; Kuzushima T
    Nihon Rinsho; 1995 Jul; 53(7):1619-22. PubMed ID: 7629998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
    Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
    Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
    Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
    Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue.
    Serini G; Trusolino L; Saggiorato E; Cremona O; De Rossi M; Angeli A; Orlandi F; Marchisio PC
    J Natl Cancer Inst; 1996 Apr; 88(7):442-9. PubMed ID: 8618236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
    Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
    J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
    Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
    Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers.
    Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ
    Digestion; 2001; 64(2):111-9. PubMed ID: 11684825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling.
    Cho SW; Kim YA; Sun HJ; Ahn HY; Lee EK; Yi KH; Oh BC; Park DJ; Cho BY; Park YJ
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1641-9. PubMed ID: 24848709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma.
    Scholten AN; Aliredjo R; Creutzberg CL; Smit VT
    Int J Gynecol Cancer; 2006; 16(3):1379-85. PubMed ID: 16803534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.